Overview
A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.
Description
Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation.
The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre.
Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.
Eligibility
Inclusion Criteria:
- Age equal to or greater than 18 years.
- Inability to communicate verbally or motor.
- Have a artificial airway.
- Informed consent of the family member or representative of the patient.
Exclusion Criteria:
- Previous pathology of cognitive impairment.
- Previous brain injury.
- Previous psychiatric disorder.
- Previous dementia.
- Previous chronic substance abuse.
- Previous chronic diabetics.
- Previous spinal cord injury.
- Previous severe polyneuropathy (diagnosed or suspected).
- Confirmed diagnosis of brain death.
- Continuous infusion of muscle relaxants and / or barbiturate coma.
- Level of deep sedation (RASS -5).